eNK Cells
Solid Tumors (Mesothelioma, Lung, HCC, Gastric)
Preclinical/ResearchActive
Key Facts
Indication
Solid Tumors (Mesothelioma, Lung, HCC, Gastric)
Phase
Preclinical/Research
Status
Active
Company
About Healios
Healios develops iPSC-based regenerative therapies for ophthalmology, ARDS, and oncology, aiming to deliver cures for intractable diseases.
View full company profile